Rachel Mcminn - Net Worth and Insider Trading
Rachel Mcminn Net Worth
The estimated net worth of Rachel Mcminn is at least $320,625 dollars as of 2024-09-20. Rachel Mcminn is the Chief Strategy Officer of Intercept Pharmaceuticals Inc and owns about 16,875 shares of Intercept Pharmaceuticals Inc (ICPT) stock worth over $320,625. Details can be seen in Rachel Mcminn's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Rachel Mcminn has not made any transactions after 2017-10-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Rachel Mcminn
Rachel Mcminn Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Rachel Mcminn owns 1 companies in total, including Intercept Pharmaceuticals Inc (ICPT) .
Click here to see the complete history of Rachel Mcminn’s form 4 insider trades.
Insider Ownership Summary of Rachel Mcminn
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ICPT | Intercept Pharmaceuticals Inc | 2017-10-02 | Chief Strategy Officer |
Rachel Mcminn Latest Holdings Summary
Rachel Mcminn currently owns a total of 1 stock. Rachel Mcminn owns 16,875 shares of Intercept Pharmaceuticals Inc (ICPT) as of October 2, 2017, with a value of $320,625.
Latest Holdings of Rachel Mcminn
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ICPT | Intercept Pharmaceuticals Inc | 2017-10-02 | 16,875 | 19.00 | 320,625 |
Holding Weightings of Rachel Mcminn
Rachel Mcminn Form 4 Trading Tracker
According to the SEC Form 4 filings, Rachel Mcminn has made a total of 0 transactions in Intercept Pharmaceuticals Inc (ICPT) over the past 5 years. The most-recent trade in Intercept Pharmaceuticals Inc is the sale of 283 shares on October 2, 2017, which brought Rachel Mcminn around $16,666.
Insider Trading History of Rachel Mcminn
- 1
Rachel Mcminn Trading Performance
Rachel Mcminn Ownership Network
Rachel Mcminn Owned Company Details
What does Intercept Pharmaceuticals Inc do?
Who are the key executives at Intercept Pharmaceuticals Inc?
Rachel Mcminn is the Chief Strategy Officer of Intercept Pharmaceuticals Inc. Other key executives at Intercept Pharmaceuticals Inc include EVP & Chief Financial Officer Andrew Saik , President & R&D and CMO M Michelle Berrey , and Chief Accounting Officer Rocco Venezia .
Intercept Pharmaceuticals Inc (ICPT) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Intercept Pharmaceuticals Inc (ICPT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Intercept Pharmaceuticals Inc (ICPT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Intercept Pharmaceuticals Inc (ICPT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Intercept Pharmaceuticals Inc Insider Transactions
Rachel Mcminn Mailing Address
Above is the net worth, insider trading, and ownership report for Rachel Mcminn. You might contact Rachel Mcminn via mailing address: C/o Intercept Pharmaceuticals, Inc., 450 W. 15th St., Ste. 505, New York Ny 10011.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
